In fact, a brand-name drug's generic counterpart is rarely an exact replica. 实际上,针对著名上市药物的仿制药极少能够实现精确的仿制。
Meanwhile, a Senate committee last week approved a bipartisan bill that would prohibit brand-name drug manufacturers from using settlement agreements to keep generic equivalents off the market. 上周参议院的相关委员会批准了一项两党联合提案,要求禁止品牌药公司通过专利和解的方式推迟仿制药的上市。